コーパス検索結果 (left1)
  通し番号をクリックするとPubMedの該当ページを表示します
  
   1                                              PKC activation triggers down-regulation of Kv1.3 by indu
     2                                              PKC directly phosphorylated PSD-95 and JNK1 in vitro Inh
     3                                              PKC inhibition or the exchange of threonine for alanine 
     4                                              PKC inhibitor GF109203X nearly abolished PTP in both con
     5                                              PKC signaling is thus implicated in autocrine regulation
     6 ing subunit 85 (MBS85), paxillin and CPI-17 (PKC-potentiated protein phosphatase 1 inhibitor protein 
  
     8 ule in which Ca(2+)-protein kinase C (Ca(2+)-PKC) is hypothesized to phosphorylate myristoylated alan
  
  
  
  
    13 hen neurons are treated with calphostin C, a PKC inhibitor that targets the diacylglycerol-binding si
  
  
    16 c-2 gene disruption abrogated thermotaxis; a PKC-2 transgene, driven by endogenous pkc-2 promoters, r
  
  
  
    20 ates diacylglycerol, which in turn activates PKC which induces the actin cytoskeleton reorganization 
  
  
  
    24 ide gene enhancer in B-cell inhibitor-alpha (PKC-alpha/IkappaB-alpha)-mediated or calcineurin/IkappaB
    25 y, and bipolar cell (protein kinase C-alpha [PKC-alpha] and recoverin) immunofluorescence revealed th
  
  
    28  EGF stimulation also elicited a Ca(2+)- and PKC-dependent reduction in synaptojanin1 recruitment to 
  
  
  
    32 was prevented, the carbachol-induced DAG and PKC responses were somewhat reduced, but PKCbetaI transl
    33 glycerol content and reduced PKC-epsilon and PKC-theta activity in liver and muscle respectively.    
  
  
    36  Furthermore, by treating WT, OX40(-/-), and PKC-(-/-) mice with soluble OX40L we established that OX
  
    38 and varepsilon-dependent phosphorylation and PKC-independent, DAG-mediated membrane recruitment, poss
    39 vitro by multiple kinases, including PKA and PKC, and pharmacological activation of these kinases enh
    40 protein for Protein Kinases A and C (PKA and PKC, respectively), AKAP facilitates phosphorylation and
    41 ently down-regulated novel PKCs PKCdelta and PKC, differences in Ca(2+) sensitivity and diacylglycero
    42 glucocorticoid-inducible kinase 1 (SGK1) and PKC-alpha was absent in Rictorfl/fl Ksp-Cre mice, indica
  
  
  
    46 rt is mainly caused by a Cdc42- and atypical PKC-dependent inhibition of dynein-dependent retrograde 
  
  
  
  
    51 tivity were partially prevented by the broad PKC inhibitor Go6983 and fully prevented by the specific
  
  
  
  
  
  
  
  
    60 athway involving sustained protein kinase C (PKC) activation, inhibition of serine/threonine phosphat
  
    62 cked with H89, or when the protein kinase C (PKC) activity was blocked with bisindolylmaleimide II (B
  
  
    65  localized the dynamics of protein kinase C (PKC) and extracellular signal-regulated kinase (ERK) act
    66 or, phospholipase C (PLC), protein kinase C (PKC) and phosphoinositide-3-kinase (PI3K), and subsequen
    67 nstrate that activation of protein kinase C (PKC) by phorbol myristate acetate, Gq/11-coupled GPCR, o
    68 gh various kinases such as protein kinase C (PKC) contribute to the expression of long-term plasticit
  
  
  
    72 a1 (PLCgamma1), Ca(2+), or protein kinase C (PKC) impair clathrin-mediated endocytosis of EGFR, the f
    73  endocytosis and activated protein kinase C (PKC) in the cytosol and extracellular signal regulated k
  
    75 lpain-mediated cleavage of protein kinase C (PKC) isoforms, each form of LTF is sensitive to a distin
    76 bition of the conventional protein kinase C (PKC) isoforms, particularly PKCalpha, reduced phosphoryl
    77 lase (HDAC) inhibitors and protein kinase C (PKC) modulators, provides a promising strategy to reduce
    78 nhibitors for PLCgamma1 or protein kinase C (PKC) pathways, while treatment with the PKC stimulator 1
    79  (PLC)beta1 activities and protein kinase C (PKC) phosphorylation, although it is unclear how store d
  
  
  
    83 a novel axis whereby WNT5a/protein kinase C (PKC) signaling regulates specific beta-catenin/co-activa
    84 n model of phospholipase C/protein kinase C (PKC) signaling, which was recently identified as a requi
  
  
    87 rmacophores for binding to protein kinase C (PKC) together with a modified bryostatin-like A- and B-r
    88 rbol ester binding site of protein kinase C (PKC), induces translocation of PKC to the cell membrane,
    89 ated protein 43 (GAP43), a protein kinase C (PKC)-activated phosphoprotein, is often implicated in ax
  
    91  is associated with rapid, protein kinase C (PKC)-dependent ClC-1 Cl(-) channel inhibition in rodent 
    92 P results primarily from a protein kinase C (PKC)-dependent increase in release probability (Pr ) and
    93 is known to trigger rapid, protein kinase C (PKC)-dependent inhibition of ClC-1 Cl(-) ion channels in
  
    95 olog 1 (Dlgh1) and exclude protein kinase C (PKC)-theta from immunological synapses formed on support
  
  
  
  
   100  and augmented activity of protein kinase C (PKC)alpha/beta, which was dissociated from PP2A and incr
   101 kinase (IRAK)1, MyD88, and protein kinase C (PKC)epsilon to the downstream TLR-signaling complex that
   102 mechanistic understanding of phospholipase C/PKC signaling in chemotactic gradient sensing and can gu
  
  
   105 oprecipitation and pulldown assays confirmed PKC and beta-catenin as binding partners and revealed th
  
   107  did not affect PKCbetaI; thus, conventional PKCs appear generally insensitive to desensitization by 
   108 hat thermotaxis is controlled by cooperative PKC-2-mediated signaling in both AFD sensory neurons and
  
  
   111  CLR endocytosis and activation of cytosolic PKC and nuclear ERK, which derive from endosomal CLR.   
  
  
   114 gamma pathway activates mTOR through the DAG/PKC signaling branch, independent of the conventional Ak
  
   116 regulation of beta-catenin levels and define PKC as an important beta-catenin interaction partner and
   117 ed downregulation of protein kinase C-delta (PKC-delta), a TLR4-associated signalling mediator requir
   118 armacological inhibition of Ca(2+)-dependent PKC isoforms abolished fast alpha1B receptor desensitiza
   119 tion, this work elucidates the ADO-dependent PKC-mediated molecular mechanism that triggers immunomod
   120 ut (TKO) mice in which all calcium-dependent PKC isoforms have been eliminated (PKCalpha, PKCbeta, an
   121 ts onto deprived PV cells through downstream PKC-dependent activation and AMPA receptor exocytosis, t
  
  
   124  and PDAC of Pdx1-Cre;Kras(G12D/+);p53(f/+) (PKC) mice as early as 2 mo, suggesting that GRP78 could 
  
  
  
   128 ies of different PKM isoforms generated from PKCs by calpain-mediated cleavage maintain two forms of 
  
  
  
  
  
  
   135 r control conditions it rose dramatically if PKC-dependent ClC-1 inhibition had been prevented with t
  
   137 On the other hand, a significant decrease in PKC activity, and inhibition of nuclear factor kappa B (
   138 ingly, the single and combined deficiency in PKC-theta or CARMA-1-the two signal transducers at the N
  
   140      Further, beta-catenin overexpression in PKC-deficient podocytes could restore the wild-type phen
   141 in-1 phosphorylation is an essential step in PKC-dependent potentiation of synaptic transmission, act
  
  
   144 - and PKC-mediated) and agonist-independent (PKC-promoted) KOPR phosphorylations show distinct phosph
  
  
   147  on its relocalisation, but that PMA-induced PKC activity drastically dysregulates the localisation o
   148 orylated PSD-95 and JNK1 in vitro Inhibiting PKC, JNK, or calcium/calmodulin-dependent kinase II acti
   149 fen analog, 6c, which more potently inhibits PKC than tamoxifen but lacks affinity for the estrogen r
   150 , introgression of the Bcl2l1 transgene into PKC-theta null mouse failed to rescue NKT cell developme
   151 totagmin-1 (Syt1(T112A)), which prevents its PKC-dependent phosphorylation, abolishes DAG-induced pot
   152 ral cell signaling cascades, like NF-kappaB, PKC, ERK, and MAPK, that are involved in autophagy and s
   153 tially suppressed by inhibitor of NF-kappaB, PKC, or ERK alone and significantly in combination.     
  
  
  
   157 , including WN-8, for which "bryostatin-like PKC modulatory activities" previously was suggested sole
   158 ich C kinase substrate by membrane-localized PKC constitutes a positive feedback that is sufficient f
  
  
   161  inhibitor of PKC, calphostin C, blocks mbGR/PKC pathway, and rescues GC-mediated inhibition of kerat
  
   163      After U50,488H treatment, GRKs, but not PKC, were involved in agonist-induced KOPR internalizati
   164 er U50,488H treatment, GRK-mediated, but not PKC-mediated, KOPR phosphorylation followed by beta-arre
  
  
  
   168 though DiC8 efficiently down-regulated novel PKCs PKCdelta and PKC, differences in Ca(2+) sensitivity
  
  
  
  
   173 8 and TRIF pathways and to the activation of PKC, MAP kinase, and NF-kappaB signaling to induce the p
  
  
  
  
   178 mmatory DC responses and indeed, blocking of PKC-delta degradation by the autophagolysosomal inhibito
   179 s study, we tested optimal concentrations of PKC agonist candidates (PEP005/Ingenol-3-angelate, prost
  
  
   182 LTD expression by facilitating the effect of PKC on the dissociation of AMPARs from GRIP and thus the
  
  
  
  
  
  
  
  
  
  
  
   194 f this enzyme family, discusses the roles of PKC enzymes in the development and effector functions of
  
   196 lating catalytic activation and stability of PKC family members to allow for flexible and dynamic con
   197 ein kinase C (PKC), induces translocation of PKC to the cell membrane, and activates kinase activity.
  
  
   200  PKMs, the constitutively active isoforms of PKCs generated by calpain cleavage, in the sensory neuro
   201 r DAG spiking causes membrane recruitment of PKCs and whether different classes of PKCs show characte
   202 tion prevented intermittent translocation of PKCs and reduced insulin secretion but did not affect [C
  
   204 lity of active human muscle fibres relies on PKC-dependent ClC-1 inhibition via a gating mechanism.  
   205 sent in TRPC1(-/-) cells, and store-operated PKC phosphorylation of TRPC1 was inhibited by STIM1 shRN
  
  
  
  
   210    Second, subthreshold inhibition of PKA or PKC phosphorylation did not prevent TAAR1 suppression of
  
   212 y activated enzyme that acts much like other PKC isoforms to transduce growth factor-dependent signal
  
  
  
   216   Succinate increases phosphorylation of pan-PKC, especially the atypical PKCzeta level which was blo
  
   218 re-directed behaviors elicited by persistent PKC-2 activation or inhibition in AFD (or intestine) dis
  
  
  
   222 ivation of common (AC/PKA) and distinct (PLC/PKC, intra-/extra-cellular calcium, PI3K/MAPK/mTOR) sign
  
  
  
  
  
   228 ial molecular mediator to integrate positive PKC-theta-dependent TCR signals to induce peak RORgammat
  
   230    Knockdown of either PKC or JNK1 prevented PKC activator-mediated membrane accumulation of PSD-95. 
  
   232 ylation of the downstream signaling protein, PKC-alpha, and Ca(2+)/calmodulin-dependent protein kinas
   233 luded inositol 1,3,5-triphosphate receptors, PKC, and enhancement of filamentous-actin turnover.     
   234 ctions in diacylglycerol content and reduced PKC-epsilon and PKC-theta activity in liver and muscle r
  
  
  
  
   239 ction microscopy, fluorescent protein-tagged PKCs, and signaling biosensors, we investigated whether 
  
  
   242  Taken together, these data demonstrate that PKC-mediated lamin phosphorylation is a conserved mechan
   243 ibition in AFD (or intestine) disclosed that PKC-2 regulates initiation and duration of cryophilic dr
  
  
  
  
  
   249 stimulation of both cell types revealed that PKC positively regulates beta-catenin expression and sta
  
  
  
  
  
  
   256 Collectively, our data strongly suggest that PKC activation by stolonidiol is responsible for the res
   257 by UTP in control epithelia, suggesting that PKC-mediated phosphorylation plays a permissive role in 
  
  
  
   261 KC inhibitor GF109203 eliminates PTP and the PKC activator PDBu enhances neurotransmitter release and
   262 ntibodies, the PLC inhibitor U73122, and the PKC inhibitor GF109203X all inhibited activation of TRPC
  
  
  
  
   267 nd find that in wild-type mice 10 mum of the PKC inhibitor GF109203 eliminates PTP and the PKC activa
   268 in crd1Delta cells, and up-regulation of the PKC pathway by expression of the PKC1(R398P) gene, which
  
  
   271 3) the changes of the major molecules of the PKC-alpha/IkappaBalpha- and calcineurin/IkappaB-beta-dep
  
  
  
   275 he changes in ClC-1 gating that underlie the PKC-dependent ClC-1 inhibition in active muscle using hu
   276 e C (PKC) pathways, while treatment with the PKC stimulator 12-O-tetradecanoylphorbol-13-acetate rest
   277 ) signaling molecule protein kinase C theta (PKC-theta)-mediated phosphorylation of SRC1 is important
  
   279 ners and revealed that ablation of the three PKC phosphorylation sites weakens their interaction.    
  
  
   282 6 and Merle 47 exhibited binding affinity to PKC alpha with Ki values of 7000 +/- 990 and 4940 +/- 47
   283 rmore, we found that beta-arrestin2 binds to PKC-phosphorylated AT1R in a distinct active conformatio
  
  
  
  
  
  
  
  
  
  
   294 er, many of the detailed mechanisms by which PKC induces synaptogenesis are not fully understood.    
  
  
   297  lower beta-catenin expression compared with PKC wild-type mice, consistent with an altered phenotype
  
   299 The model reveals how PTPMEG cooperates with PKC to drive LTD expression by facilitating the effect o
   300 form-targeted HDAC inhibitors synergize with PKC modulators, namely bryostatin-1 analogues (bryologs)
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。